Comparing Magnesium Glycinate and Melatonin Supplements for Treating Primary Insomnia in Young Adults Ages 18 to 40

What this Trial Is About

Sleep is essential for overall health and well-being, influencing many body functions. Researchers are studying the effectiveness of magnesium supplements compared to melatonin congeners in young adults who have primary insomnia. Unlike most insomnia studies focusing on older adults or those with other health issues, this trial targets healthy young adults aged 18 to 40 to provide age-specific insights. Participants will be randomly assigned to one of two groups for a 4-week treatment period. One group will take oral magnesium glycinate tablets at a dose of 500 mg nightly, while the other group will take oral melatonin tablets at 10 mg nightly. Both treatments are given as tablets and taken once each night. During the study, participants will be monitored for changes in their insomnia severity using the Insomnia Severity Index over the 4 weeks. Researchers will evaluate sleep difficulties and related daytime impairments. Participants will be assessed at regular intervals to track the effectiveness and impact of the supplements on their sleep patterns.

Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia